Acute Porphyria Drug Database

Monograph

B01AD07 - Reteplase
Not porphyrinogenic
NP

Rationale
Recombinant enzyme. No CYP-interactions.
Chemical description
Recombinant enzymatic plasmin activator administered as infusion within 12 hour after herat infarction.
Similar drugs
Explore alternative drugs in similar therapeutic classes B01A / B01AD or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Rapilysin Rapilysin Rapilysin Rapilysin Rapilysin
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙